(Medical Xpress)—Harvard Medical School researchers at Joslin Diabetes Center have created the first induced pluripotent stem cells (iPSCs) that offer a human model of insulin resistance, a key driver of type 2 diabetes.
Aug 1, 2014
0
0
Researchers at Duke Medicine have identified a new strategy for treating neuroblastoma using a modified version of heparin, a century-old injectable drug that thins the blood to prevent clots from forming.
Jun 17, 2014
0
0
Hepatocyte (liver cell) transplantation is becoming an accepted therapy for acute liver failure, either for liver regeneration or as a bridge to liver transplantation. However, maintaining the viability and functional aspects ...
Dec 18, 2013
0
0
Osteogeneis imperfecta (OI) is a congenital bone disease that causes stunted growth and repeated, painful fracturing. Ultrasound scans can reveal fractures already in the fetus, and now an international team of researchers ...
Dec 16, 2013
0
0
Vaginal delivery presents the possibility of injury for mothers that can lead to "stress urinary incontinence" (SUI), a condition affecting from four to 35 percent of women who have had babies via vaginal delivery. Many current ...
Sep 17, 2013
0
0
A regenerative tissue product developed by a Perth health care group has the potential to help tissue heal better than existing products when used in cardiac repairs.
Sep 10, 2013
0
1
A team of international researchers from Duke-NUS Graduate Medical School Singapore and the Johns Hopkins University School of Medicine (USA) has identified a self-perpetuating signaling circuit inside connective tissue cells ...
Jul 16, 2013
0
0
With fewer than 5 percent of sufferers surviving beyond five years of diagnosis, pancreatic cancer is one of the most lethal of all cancers. Late diagnosis is one reason for these statistics, but so is the aggressive nature ...
Jun 28, 2013
0
1
Scientists at the University of East Anglia have made a major advancement in understanding tissue development that has important implications for cancer.
Jun 26, 2013
0
0
Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, ...
Jun 11, 2013
0
0
